DENISE WILEY: Open Payments
NPI 1841963352 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,373 in 51 payments from 17 companies in 2025. Trend: 2023 $527 · 2024 $801 · 2025 $1,373
Food & beverage: $1,183Education: $190
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 5 | $358 |
| GlaxoSmithKline, LLC. | 17 | $227 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $193 |
| Verona Pharma, Inc. | 3 | $132 |
| United Therapeutics Corporation | 3 | $131 |
| AstraZeneca Pharmaceuticals LP | 4 | $76 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $34 |
| Travere Therapeutics, Inc. | 1 | $34 |
| Lilly USA, LLC | 1 | $28 |
| Calliditas Therapeutics US Inc. | 1 | $25 |
Products named: XYWAV, GLASSIA, TRELEGY ELLIPTA, Ohtuvayre, TYVASO, AIRSUPRA, DUPIXENT, NUCALA.
Industry payments across NV — which companies pay providers there.
